161 related articles for article (PubMed ID: 17466918)
1. Intravenous administration of MIP-1alpha with intra-tumor injection of P. acnes shows potent anti-tumor effect.
Nakano A; Yoneyama H; Ueha S; Kitabatake M; Ishikawa S; Kawase I; Sugiyama H; Matsushima K
Int Immunopharmacol; 2007 Jun; 7(6):845-57. PubMed ID: 17466918
[TBL] [Abstract][Full Text] [Related]
2. Administration of MIP-3alpha gene to the tumor following radiation therapy boosts anti-tumor immunity in a murine model of lung carcinoma.
Zhu B; Zou L; Cheng X; Lin Z; Duan Y; Wu Y; Zhou F; Chen Z
Immunol Lett; 2006 Mar; 103(2):101-7. PubMed ID: 16257060
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells.
Shinagawa N; Yamazaki K; Tamura Y; Imai A; Kikuchi E; Yokouchi H; Hommura F; Oizumi S; Nishimura M
Cancer Immunol Immunother; 2008 Feb; 57(2):165-74. PubMed ID: 17628800
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral expression of MIP-1beta induces antitumor responses in a pre-established tumor model through chemoattracting T cells and NK cells.
Luo X; Yu Y; Liang A; Xie Y; Liu S; Guo J; Wang W; Qi R; An H; Zhang M; Xu H; Guo Z; Cao X
Cell Mol Immunol; 2004 Jun; 1(3):199-204. PubMed ID: 16219168
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of MIP-1alpha-recruited dendritic cells on preestablished solid and metastatic tumors.
Cao Q; Jin Y; Jin M; He S; Gu Q; He S; Qiu Y; Ge H; Yoneyama H; Zhang Y
Cancer Lett; 2010 Sep; 295(1):17-26. PubMed ID: 20202744
[TBL] [Abstract][Full Text] [Related]
6. Expression of inflammatory chemokines combined with local tumor destruction enhances tumor regression and long-term immunity.
Crittenden M; Gough M; Harrington K; Olivier K; Thompson J; Vile RG
Cancer Res; 2003 Sep; 63(17):5505-12. PubMed ID: 14500387
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral gene transfer of stromal cell-derived factor-1 to murine tumors induces the accumulation of dendritic cells and suppresses tumor growth.
Fushimi T; O'Connor TP; Crystal RG
Cancer Res; 2006 Apr; 66(7):3513-22. PubMed ID: 16585175
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of spontaneous metastatic lung cancer with tumor antigen-pulsed, interleukin-18 gene-modified dendritic cells].
Chen J; Cao X; Xiu Q
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):779-82. PubMed ID: 11798964
[TBL] [Abstract][Full Text] [Related]
9. Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation.
Jin GH; Hirano T; Murakami M
Int Immunol; 2008 Jun; 20(6):783-9. PubMed ID: 18448458
[TBL] [Abstract][Full Text] [Related]
10. Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity.
Machlenkin A; Goldberger O; Tirosh B; Paz A; Volovitz I; Bar-Haim E; Lee SH; Vadai E; Tzehoval E; Eisenbach L
Clin Cancer Res; 2005 Jul; 11(13):4955-61. PubMed ID: 16000595
[TBL] [Abstract][Full Text] [Related]
11. Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model.
Pender SL; Chance V; Whiting CV; Buckley M; Edwards M; Pettipher R; MacDonald TT
Gut; 2005 Aug; 54(8):1114-20. PubMed ID: 16009684
[TBL] [Abstract][Full Text] [Related]
12. A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice.
Uekusa Y; Yu WG; Mukai T; Gao P; Yamaguchi N; Murai M; Matsushima K; Obika S; Imanishi T; Higashibata Y; Nomura S; Kitamura Y; Fujiwara H; Hamaoka T
Cancer Res; 2002 Jul; 62(13):3751-8. PubMed ID: 12097285
[TBL] [Abstract][Full Text] [Related]
13. Mobilization of dendritic cell precursors into the circulation by administration of MIP-1alpha in mice.
Zhang Y; Yoneyama H; Wang Y; Ishikawa S; Hashimoto S; Gao JL; Murphy P; Matsushima K
J Natl Cancer Inst; 2004 Feb; 96(3):201-9. PubMed ID: 14759987
[TBL] [Abstract][Full Text] [Related]
14. Activation and route of administration both determine the ability of bone marrow-derived dendritic cells to accumulate in secondary lymphoid organs and prime CD8+ T cells against tumors.
Huck SP; Tang SC; Andrew KA; Yang J; Harper JL; Ronchese F
Cancer Immunol Immunother; 2008 Jan; 57(1):63-71. PubMed ID: 17609951
[TBL] [Abstract][Full Text] [Related]
15. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
17. Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta.
Tedla N; Wang HW; McNeil HP; Di Girolamo N; Hampartzoumian T; Wakefield D; Lloyd A
J Immunol; 1998 Nov; 161(10):5663-72. PubMed ID: 9820547
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours.
Chandy AG; Nurkkala M; Josefsson A; Eriksson K
Vaccine; 2007 Aug; 25(32):6037-46. PubMed ID: 17629599
[TBL] [Abstract][Full Text] [Related]
19. Infiltrating neutrophils induce allospecific CTL in response to immunization with apoptotic cells via MCP-1 production.
Shiratsuchi Y; Iyoda T; Tanimoto N; Kegai D; Nagata K; Kobayashi Y
J Leukoc Biol; 2007 Feb; 81(2):412-20. PubMed ID: 17095610
[TBL] [Abstract][Full Text] [Related]
20. Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses.
Edukulla R; Woller N; Mundt B; Knocke S; Gürlevik E; Saborowski M; Malek N; Manns MP; Wirth T; Kühnel F; Kubicka S
Cancer Res; 2009 Feb; 69(4):1448-58. PubMed ID: 19190348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]